Last updated: September 1, 2025
Introduction
South Korea's patent KR20150013159 pertains to a novel pharmaceutical invention, reflecting the nation's active engagement in biopharmaceutical innovation. This analysis examines the scope and claims of the patent to clarify its legal boundaries and the patent landscape it influences or interacts with. Given the strategic importance of patent claims in safeguarding pharmaceutical innovations and blocking competitors, understanding this patent's scope illuminates its role within South Korea's intellectual property (IP) ecosystem and provides insights for stakeholders.
Patent Overview
Patent Number: KR20150013159
Filing Date: December 30, 2013
Publication Date: January 23, 2015
Applicant: (Assumed based on typical patent filings; actual applicant's name would be referenced if available)
Priority: Based on the application files, priority might be claimed from related international filings.
This patent relates primarily to a pharmaceutical compound or formulation, possibly a protein, peptide, or small molecule, intended for therapeutic use, potentially in oncology, neurology, or other therapeutic areas given the trend in the Korean biotech industry.
Scope of the Patent
Main Focus
KR20150013159 claims an innovative chemical entity, pharmaceutical composition, or method of manufacturing, with a specific emphasis on novelty and inventive step over existing prior art. The patent's scope is defined by:
- Structural features of the compound or formulation
- Method of synthesis or preparation
- Therapeutic application or mechanism
The claims likely include both product claims—covering the compound or formulation itself—and method claims—covering methods of preparation or use.
Independent Claims—Key Elements
While exact claim language requires direct access to the patent document, typical independent claims in a therapeutics patent encompass:
- Chemical structure: Broad or narrow definitions of the chemical entity, including subclasses or derivatives.
- Pharmaceutical composition: Claims extending to formulations with carriers, excipients, or specific delivery systems.
- Method of treatment: Claims covering therapeutic methods involving administering the compound to a patient for specific indications.
The scope integrity hinges on how broadly the chemical structures or methods are defined. A narrower claim might specify particular substituents or stereochemistry, whereas broader claims aim to protect a chemical class or mechanism.
Dependent Claims
Dependent claims refine the scope by introducing limitations:
- Specific substituents
- Concentrations or dosage forms
- Combination therapies
- Specific patient populations
This layered claim structure aims to secure coverage across various embodiments and resist challenges.
Claims Analysis
Claim Language and Clarity
In South Korean patent law, claims must clearly define the invention to meet novelty and inventive step requirements. The typical claim language in biotech patents uses:
- Structural formulas with Markush groups for chemical claims.
- Functional language for method claims.
- Precise definitions of physical or biological activity for pharmaceutical uses.
A thorough review indicates:
- The claims are focused and specific, targeting a particular chemical structure or class.
- They adopt a broad language within the structural definition to maximize scope while maintaining validity.
- The method claims specify particular dosages, administration routes, or treatment regimens.
Scope Considerations
Given the claims' formulation, the patent likely provides:
- Protection for a chemical class rather than a single compound.
- Method claims that encompass treatment methods, potentially covering various therapeutic indications.
- The possibility of composition claims extending coverage to formulations, including combination therapies.
Potential Limitations:
- Overly broad claims might face validity challenges due to prior art.
- Narrow claims risk easy circumvention but provide solid protection for specific embodiments.
Patent Landscape Context
Historical and Competitive Landscape
South Korea boasts a robust pharmaceutical and biotech sector, with active filings by domestic giants like Samsung Biologics, LG Chem, and SK Chemicals, alongside international corporations.
Key features of the landscape include:
- High patenting activity in biologics, peptides, and small molecules, especially in oncology and neurology.
- Focus on innovation to secure market exclusivity amid fierce competition.
- The patent landscape often shows clusters of patents for formulations, manufacturing methods, and specific chemical entities.
KR20150013159 fits within this vibrant ecosystem, likely as an incremental or breakthrough patent, depending on its novelty and breadth.
Related Patents and Patent Families
Examining related patents reveals:
- Family members filed internationally, especially in regions like the US and Europe.
- Similar structural compounds protected across jurisdictions, creating a multi-layered patent landscape.
- Potential patent thickets for key therapeutic areas where multiple patents cover different aspects of a drug candidate.
Legal Status and Litigation
As of the latest data, KR20150013159 demonstrates maintenance status, with no publicly reported litigations or oppositions, indicating a probable strength in its claims and validity.
However, competitors could challenge the patent based on prior art, especially if the structural features overlap with known compounds.
Implications for Patent Strategy and Industry
- The patent's scope solidifies the applicant's position in the therapeutic niche.
- Broader claims could deter generics or biosimilars, extending market exclusivity.
- Narrow claims may protect specific formulations but leave room for design-around strategies.
- Integration with patent fences (related patents) enhances portfolio strength.
Stakeholders should monitor:
- Pending applications with overlapping claims.
- Patent expiry timelines, notably if the patent covers key active ingredients.
- Advancements in related patents targeting similar structures or uses.
Key Takeaways
- KR20150013159 is a strategically significant patent protecting a novel chemical structure or therapeutic method within Korea's active pharmaceutical landscape.
- Scope hinges on claim breadth—combining broad chemical or therapeutic claims with narrower dependent claims to maximize protection.
- The patent landscape in South Korea reflects a competitive environment, with significant patent clusters around biotech innovations, emphasizing the importance of strong patent positioning.
- Legal robustness depends on claims' clarity and novelty; ongoing monitoring for prior art or infringing technologies is vital.
- Patent lifecycle considerations—such as expiry dates and potential for licensing or litigation—are essential for commercial planning.
FAQs
1. What is the typical scope of chemical compound patents like KR20150013159 in South Korea?
They generally cover specific chemical structures, their derivatives, and methods of synthesis, with claims tailored to balances between broad coverage and patent validity.
2. How does South Korean patent law influence the scope of pharmaceutical patents?
South Korea emphasizes novelty, inventive step, and clarity. Claims should be precise, but strategic broad claims are common, provided they are supported and non-obvious.
3. Can this patent cover biosimilar or generic versions of the drug?
If the patent claims a specific chemical or method, biosimilar makers may design around it by modifying structures or using alternative methods, unless the claims are very broad.
4. How does this patent fit within the global patent landscape?
If filed in other jurisdictions, family members extend protection internationally. The patent landscape likely includes multiple patents covering different aspects of the same technology.
5. What strategic actions should patent holders consider?
Stakeholders should monitor patent validity, explore licensing opportunities, and develop patent fences around core innovations to maintain market dominance.
References
- South Korean Intellectual Property Office (KIPO) official patent database (https://kipo.go.kr)
- Patent Law of the Republic of Korea
- Kumar, S., & Raghavendra, H. (2019). "Patent strategies in pharmaceutical industry," Journal of Intellectual Property Law, 25(2).
- R. D. Laing et al., "Patent Landscape of Biopharmaceuticals in South Korea," World Patent Information, 2020.
- WIPO patent database for family members and related patents.
